Cargando…

Cell-type-resolved quantitative proteomics map of interferon response against SARS-CoV-2

The commonly used laboratory cell lines are the first line of experimental models to study the pathogenicity and performing antiviral assays for emerging viruses. Here, we assessed the tropism and cytopathogenicity of the first Swedish isolate of SARS-CoV-2 in six different human cell lines, compare...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saccon, Elisa, Chen, Xi, Mikaeloff, Flora, Rodriguez, Jimmy Esneider, Szekely, Laszlo, Vinhas, Beatriz Sá, Krishnan, Shuba, Byrareddy, Siddappa N., Frisan, Teresa, Végvári, Ákos, Mirazimi, Ali, Neogi, Ujjwal, Gupta, Soham
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056843/ https://www.ncbi.nlm.nih.gov/pubmed/33898942 http://dx.doi.org/10.1016/j.isci.2021.102420

Ejemplares similares

Type-I interferon signatures in SARS-CoV-2 infected Huh7 cells
por: Chen, Xi, et al.
Publicado: (2021)

Utility of Proteomics in Emerging and Re-Emerging Infectious Diseases Caused by RNA Viruses
por: Sperk, Maike, et al.
Publicado: (2020)

Dysregulation in Akt/mTOR/HIF-1 signaling identified by proteo-transcriptomics of SARS-CoV-2 infected cells
por: Appelberg, Sofia, et al.
Publicado: (2020)

In silico and in vitro studies reveal complement system drives coagulation cascade in SARS-CoV-2 pathogenesis
por: Tiwari, Ritudhwaj, et al.
Publicado: (2020)

Cytotoxic Lymphocytes Target HIV-1 Gag Through Granzyme M-Mediated Cleavage
por: Saccon, Elisa, et al.
Publicado: (2021)

Integrative proteo-transcriptomic and immunophenotyping signatures of HIV-1 elite control phenotype: A cross-talk between glycolysis and HIF signaling
por: Akusjärvi, Sara Svensson, et al.
Publicado: (2021)

Metabolic Perturbation Associated With COVID-19 Disease Severity and SARS-CoV-2 Replication
por: Krishnan, Shuba, et al.
Publicado: (2021)

Peripheral blood CD4(+)CCR6(+) compartment differentiates HIV-1 infected or seropositive elite controllers from long-term successfully treated individuals
por: Svensson Akusjärvi, Sara, et al.
Publicado: (2022)

Coordinated pyruvate kinase activity is crucial for metabolic adaptation and cell survival during mitochondrial dysfunction
por: Zhou, Xiaoshan, et al.
Publicado: (2021)

Proteomic landscape of astrocytes and pericytes infected with HIV/SARS-CoV-2 mono/co-infection, impacting on neurological complications
por: Acharya, Arpan, et al.
Publicado: (2023)

Nucleoside-Modified mRNA Vaccines Protect IFNAR(–/–) Mice against Crimean-Congo Hemorrhagic Fever Virus Infection
por: Appelberg, Sofia, et al.
Publicado: (2022)

Distinct lipid profile, low-level inflammation, and increased antioxidant defense signature in HIV-1 elite control status
por: Sperk, Maike, et al.
Publicado: (2021)

Role of myeloid cells in system-level immunometabolic dysregulation during prolonged successful HIV-1 treatment
por: Svensson Akusjärvi, Sara, et al.
Publicado: (2023)

The central role of the glutamate metabolism in long-term antiretroviral treated HIV-infected individuals with metabolic syndrome
por: Gelpi, Marco, et al.
Publicado: (2021)

Trans cohort metabolic reprogramming towards glutaminolysis in long-term successfully treated HIV-infection
por: Mikaeloff, Flora, et al.
Publicado: (2022)

Multi-omics insights into host-viral response and pathogenesis in Crimean-Congo hemorrhagic fever viruses for novel therapeutic target
por: Neogi, Ujjwal, et al.
Publicado: (2022)

Distinct Metabolic Profile Associated with a Fatal Outcome in COVID-19 Patients during the Early Epidemic in Italy
por: Saccon, Elisa, et al.
Publicado: (2021)

Systems-level temporal immune-metabolic profile in Crimean-Congo hemorrhagic fever virus infection
por: Ambikan, Anoop T., et al.
Publicado: (2023)

Following the path: Increasing trends of HIV-1 drug resistance in China
por: Gupta, Soham, et al.
Publicado: (2020)

Feasibility of Known RNA Polymerase Inhibitors as Anti-SARS-CoV-2 Drugs
por: Neogi, Ujjwal, et al.
Publicado: (2020)

Transcriptomics age acceleration in prolonged treated HIV infection
por: Mikaeloff, Flora, et al.
Publicado: (2023)

Genome-scale metabolic models for natural and long-term drug-induced viral control in HIV infection
por: Ambikan, Anoop T, et al.
Publicado: (2022)

Immune landscape of female reproductive tract and HIV susceptibility
por: Byrareddy, Siddappa N.
Publicado: (2021)

Single-Cell Chemical Proteomics (SCCP) Interrogates the Timing and Heterogeneity of Cancer Cell Commitment to Death
por: Végvári, Ákos, et al.
Publicado: (2022)

Rapamycin as a potential repurpose drug candidate for the treatment of COVID-19
por: Husain, Amjad, et al.
Publicado: (2020)

SARS-CoV2 induced respiratory distress: Can cannabinoids be added to anti-viral therapies to reduce lung inflammation?
por: Byrareddy, Siddappa N., et al.
Publicado: (2020)

Brain endothelial cells exposure to malaria parasites links type I interferon signalling to antigen presentation, immunoproteasome activation, endothelium disruption, and cellular metabolism
por: Shafi, Abdul Muktadir, et al.
Publicado: (2023)

The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak
por: Rothan, Hussin A., et al.
Publicado: (2020)

In vitro replicative fitness of early Transmitted founder HIV-1 variants and sensitivity to Interferon alpha
por: Ashok kumar, Manickam, et al.
Publicado: (2020)

Increased acquired protease inhibitor drug resistance mutations in minor HIV-1 quasispecies from infected patients suspected of failing on national second-line therapy in South Africa
por: Obasa, Adetayo Emmanuel, et al.
Publicado: (2021)

Publisher Correction: In vitro replicative fitness of early Transmitted founder HIV-1 variants and sensitivity to Interferon alpha
por: Ashokkumar, Manickam, et al.
Publicado: (2020)

Follicular Dendritic Cells of Lymph Nodes as Human Immunodeficiency Virus/Simian Immunodeficiency Virus Reservoirs and Insights on Cervical Lymph Node
por: Dave, Rajnish S., et al.
Publicado: (2018)

Drug Repurposing Approaches to Combating Viral Infections
por: Trivedi, Jay, et al.
Publicado: (2020)

Multi-omics personalized network analyses highlight progressive disruption of central metabolism associated with COVID-19 severity
por: Ambikan, Anoop T., et al.
Publicado: (2022)

Network-based multi-omics integration reveals metabolic at-risk profile within treated HIV-infection
por: Mikaeloff, Flora, et al.
Publicado: (2023)

The expanding HIV-1 epidemic aggravates therapeutics and vaccine development programs in India
por: Neogi, Ujjwal
Publicado: (2009)

IFN-I Independent Antiviral Immune Response to Vesicular Stomatitis Virus Challenge in Mouse Brain
por: Mishra, Anurag R., et al.
Publicado: (2020)

Role of MicroRNAs in Bone Pathology during Chikungunya Virus Infection
por: Roy, Enakshi, et al.
Publicado: (2020)

Combining antiviral drugs with BET inhibitors is beneficial in combatting SARS‐CoV‐2 infection
por: Acharya, Arpan, et al.
Publicado: (2022)

Pulmonary stromal expansion and intra-alveolar coagulation are primary causes of COVID-19 death
por: Szekely, Laszlo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9fqka0p76kgeeanbvk84k6m4vr